| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
23,910,000 |
| Market
Cap: |
2.33(B) |
| Last
Volume: |
151,725 |
Avg
Vol: |
186,382 |
| 52
Week Range: |
$81.08 - $209.15 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 789 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile ICU Medical is an infusion therapy company. Co. has four product lines: Infusion Consumables, which include Clave™ needlefree products, SwabCap and SwabTip disinfecting caps, ClearGuard HD antimicrobial barrier caps for hemodialysis catheters and Tego™ hemodialysis connector used to cap and protect hemodialysis central venous catheter hubs; Infusion Systems, which provide infusion pumps, dedicated IV sets, software and other services; IV Solutions, which provide a supply of IV solutions, irrigation and nutritionals; and Critical Care, which helps clinicians get real-time access to patients' hemodynamic and cardiac status with a portfolio of monitoring systems and sensors and catheters.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
25,835 |
| Total Buy Value |
$0 |
$0 |
$0 |
$4,467,256 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
1,731,983 |
1,733,712 |
1,800,756 |
1,804,487 |
| Total Sell Value |
$183,670,269 |
$183,822,465 |
$195,804,141 |
$196,491,165 |
| Total People Sold |
6 |
6 |
8 |
8 |
| Total Sell Transactions |
12 |
13 |
17 |
23 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bonnell Brian Michael |
Chief Financial Officer |
• – – |
2021-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,272 |
3,598 |
|
- |
|
| Mcgrody Kevin J |
Chief Accounting Officer |
• – – |
2021-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,351) |
3,548 |
|
- |
|
| Mcgrody Kevin J |
Chief Accounting Officer |
• – – |
2021-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,568 |
4,014 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2021-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,194) |
11,050 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2021-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,168 |
11,866 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,103) |
12,844 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,897 |
13,776 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2021-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,267) |
8,162 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2021-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,862 |
8,790 |
|
- |
|
| Swinney Robert S |
Director |
– • – |
2021-03-02 |
4 |
S |
$207.00 |
$310,500 |
D/D |
(1,500) |
22,505 |
|
-1% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,235) |
10,050 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,044 |
14,285 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2021-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,873) |
9,076 |
|
- |
|
| Voigtlander Christian B. |
Chief Operating Officer |
• – – |
2021-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,519 |
10,949 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2021-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(554) |
1,948 |
|
- |
|
| Sanzone Virginia Ruth |
VP, General Counsel |
• – – |
2021-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,005 |
2,502 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2021-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(377) |
6,567 |
|
- |
|
| Woolson Daniel |
VP, GM-Infusion Capital |
• – – |
2021-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
804 |
6,944 |
|
- |
|
| Swinney Robert S |
Director |
– • – |
2021-02-02 |
4 |
OE |
$43.12 |
$64,680 |
D/D |
1,500 |
24,005 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-01-08 |
4 |
AS |
$220.00 |
$8,490,020 |
D/D |
(38,591) |
66,241 |
|
-11% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-01-08 |
4 |
OE |
$58.79 |
$2,268,765 |
D/D |
38,591 |
104,832 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-01-07 |
4 |
AS |
$220.00 |
$1,335,400 |
D/D |
(6,070) |
66,241 |
|
-9% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-01-07 |
4 |
OE |
$58.79 |
$356,855 |
D/D |
6,070 |
72,311 |
|
- |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-01-06 |
4 |
AS |
$220.00 |
$5,354,580 |
D/D |
(24,339) |
66,241 |
|
-9% |
|
| Jain Vivek |
Chairman and CEO |
• • – |
2021-01-06 |
4 |
OE |
$58.79 |
$1,430,890 |
D/D |
24,339 |
90,580 |
|
- |
|
157 Records found
|
|
Page 2 of 7 |
|
|
2.56 (2.7%) 
